Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anthocyanins | 21 | 2024 | 36 | 6.490 |
Why?
|
| Phenols | 13 | 2025 | 92 | 3.930 |
Why?
|
| Polyphenols | 8 | 2025 | 37 | 3.350 |
Why?
|
| Fruit | 14 | 2025 | 127 | 2.760 |
Why?
|
| Flavonoids | 14 | 2023 | 54 | 2.160 |
Why?
|
| Glucosides | 7 | 2017 | 24 | 2.050 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2017 | 38 | 1.480 |
Why?
|
| Hydroxybenzoates | 7 | 2025 | 24 | 1.290 |
Why?
|
| Diet | 7 | 2025 | 588 | 1.140 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2016 | 102 | 1.020 |
Why?
|
| Interleukin-6 | 3 | 2017 | 276 | 0.920 |
Why?
|
| Terminology as Topic | 3 | 2025 | 71 | 0.870 |
Why?
|
| Endothelial Cells | 2 | 2017 | 283 | 0.860 |
Why?
|
| Biological Availability | 7 | 2025 | 108 | 0.840 |
Why?
|
| Fragaria | 3 | 2021 | 17 | 0.840 |
Why?
|
| Metabolome | 2 | 2019 | 102 | 0.720 |
Why?
|
| Glucuronides | 3 | 2023 | 48 | 0.650 |
Why?
|
| Cardiovascular Diseases | 7 | 2021 | 491 | 0.600 |
Why?
|
| Digestion | 4 | 2022 | 29 | 0.600 |
Why?
|
| Carotenoids | 4 | 2024 | 24 | 0.590 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2018 | 7 | 0.580 |
Why?
|
| Spinacia oleracea | 3 | 2022 | 7 | 0.540 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 136 | 0.530 |
Why?
|
| Flavanones | 1 | 2017 | 5 | 0.530 |
Why?
|
| Humans | 43 | 2025 | 52469 | 0.520 |
Why?
|
| Bacteria | 3 | 2025 | 220 | 0.510 |
Why?
|
| Sambucus | 2 | 2013 | 6 | 0.500 |
Why?
|
| CD40 Ligand | 1 | 2015 | 15 | 0.470 |
Why?
|
| Beverages | 2 | 2015 | 57 | 0.470 |
Why?
|
| Cross-Over Studies | 8 | 2025 | 239 | 0.460 |
Why?
|
| Dietary Supplements | 9 | 2025 | 464 | 0.450 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2015 | 335 | 0.440 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 170 | 0.420 |
Why?
|
| Hyperinsulinism | 2 | 2024 | 30 | 0.410 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 257 | 0.380 |
Why?
|
| Ribes | 1 | 2011 | 5 | 0.360 |
Why?
|
| Food Handling | 1 | 2011 | 14 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2017 | 395 | 0.340 |
Why?
|
| Plant Extracts | 6 | 2022 | 193 | 0.340 |
Why?
|
| Catechin | 3 | 2023 | 15 | 0.330 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 184 | 0.320 |
Why?
|
| Blood Pressure | 7 | 2021 | 536 | 0.320 |
Why?
|
| Blood Glucose | 5 | 2024 | 473 | 0.320 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2022 | 250 | 0.310 |
Why?
|
| Biomedical Research | 2 | 2020 | 258 | 0.300 |
Why?
|
| Cacao | 2 | 2022 | 5 | 0.290 |
Why?
|
| Antioxidants | 3 | 2011 | 257 | 0.290 |
Why?
|
| Insulin | 4 | 2024 | 484 | 0.280 |
Why?
|
| Middle Aged | 15 | 2025 | 13084 | 0.270 |
Why?
|
| Chlorophyll | 3 | 2022 | 14 | 0.270 |
Why?
|
| Atherosclerosis | 2 | 2025 | 225 | 0.270 |
Why?
|
| Diet, High-Fat | 3 | 2024 | 237 | 0.270 |
Why?
|
| Male | 20 | 2025 | 26794 | 0.270 |
Why?
|
| Energy Intake | 2 | 2021 | 172 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 567 | 0.260 |
Why?
|
| Vascular Stiffness | 3 | 2021 | 24 | 0.260 |
Why?
|
| Lipids | 2 | 2025 | 160 | 0.260 |
Why?
|
| Plasma | 2 | 2025 | 46 | 0.260 |
Why?
|
| Metabolomics | 3 | 2025 | 151 | 0.250 |
Why?
|
| Hyperglycemia | 2 | 2024 | 89 | 0.240 |
Why?
|
| Adult | 12 | 2025 | 14151 | 0.230 |
Why?
|
| Isomerism | 2 | 2025 | 24 | 0.230 |
Why?
|
| Quercetin | 1 | 2025 | 18 | 0.230 |
Why?
|
| Blood Specimen Collection | 1 | 2025 | 35 | 0.230 |
Why?
|
| Capillaries | 1 | 2025 | 49 | 0.230 |
Why?
|
| Insulin Resistance | 2 | 2024 | 278 | 0.230 |
Why?
|
| Streptozocin | 1 | 2024 | 24 | 0.220 |
Why?
|
| Veins | 1 | 2025 | 74 | 0.220 |
Why?
|
| Hydrolysis | 3 | 2011 | 68 | 0.220 |
Why?
|
| Musa | 1 | 2024 | 4 | 0.220 |
Why?
|
| Young Adult | 5 | 2025 | 4326 | 0.210 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1586 | 0.210 |
Why?
|
| Chromatography, Liquid | 2 | 2022 | 240 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2016 | 1139 | 0.210 |
Why?
|
| Cardiovascular System | 2 | 2015 | 54 | 0.200 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 137 | 0.200 |
Why?
|
| Gene Expression | 2 | 2016 | 623 | 0.200 |
Why?
|
| Tea | 2 | 2023 | 17 | 0.200 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2023 | 28 | 0.200 |
Why?
|
| Postprandial Period | 4 | 2024 | 73 | 0.200 |
Why?
|
| Female | 16 | 2025 | 28192 | 0.190 |
Why?
|
| Hypercholesterolemia | 2 | 2021 | 39 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1897 | 0.190 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.190 |
Why?
|
| Phytotherapy | 3 | 2016 | 45 | 0.190 |
Why?
|
| Endotoxemia | 1 | 2022 | 35 | 0.180 |
Why?
|
| Colon | 2 | 2025 | 105 | 0.180 |
Why?
|
| Double-Blind Method | 5 | 2023 | 718 | 0.180 |
Why?
|
| Postmenopause | 2 | 2013 | 81 | 0.180 |
Why?
|
| Meals | 1 | 2021 | 63 | 0.170 |
Why?
|
| Eating | 1 | 2021 | 159 | 0.170 |
Why?
|
| Plant Preparations | 1 | 2020 | 41 | 0.160 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2021 | 165 | 0.150 |
Why?
|
| Dietary Proteins | 1 | 2022 | 252 | 0.150 |
Why?
|
| Brachial Artery | 1 | 2018 | 17 | 0.150 |
Why?
|
| Animals | 7 | 2025 | 13455 | 0.150 |
Why?
|
| Running | 1 | 2018 | 22 | 0.150 |
Why?
|
| Milk | 1 | 2018 | 80 | 0.140 |
Why?
|
| Mothers | 1 | 2021 | 267 | 0.140 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 293 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 599 | 0.140 |
Why?
|
| Walking | 1 | 2018 | 106 | 0.140 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 32 | 0.140 |
Why?
|
| Molecular Structure | 1 | 2018 | 315 | 0.130 |
Why?
|
| Aorta | 1 | 2018 | 170 | 0.130 |
Why?
|
| Diet, Fat-Restricted | 2 | 2024 | 13 | 0.130 |
Why?
|
| Vegetables | 1 | 2017 | 66 | 0.130 |
Why?
|
| Genotype | 3 | 2024 | 571 | 0.130 |
Why?
|
| Hypertension | 2 | 2012 | 568 | 0.130 |
Why?
|
| Equol | 1 | 2016 | 3 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2010 | 557 | 0.120 |
Why?
|
| Rats | 2 | 2021 | 3180 | 0.120 |
Why?
|
| Cell Line | 2 | 2015 | 1030 | 0.120 |
Why?
|
| Coumaric Acids | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hesperidin | 1 | 2015 | 1 | 0.120 |
Why?
|
| Pulse Wave Analysis | 3 | 2021 | 8 | 0.120 |
Why?
|
| Parabens | 2 | 2015 | 3 | 0.120 |
Why?
|
| Isoflavones | 1 | 2016 | 88 | 0.120 |
Why?
|
| Absorption | 2 | 2013 | 22 | 0.120 |
Why?
|
| Superoxides | 1 | 2015 | 46 | 0.110 |
Why?
|
| Overweight | 1 | 2017 | 224 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2015 | 83 | 0.110 |
Why?
|
| Monocytes | 1 | 2015 | 129 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1544 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 222 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1480 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1024 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1004 | 0.100 |
Why?
|
| Cholesterol, LDL | 3 | 2021 | 43 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 244 | 0.100 |
Why?
|
| Half-Life | 1 | 2013 | 87 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2288 | 0.100 |
Why?
|
| Isotope Labeling | 1 | 2013 | 58 | 0.100 |
Why?
|
| Phenotype | 1 | 2016 | 799 | 0.100 |
Why?
|
| Proanthocyanidins | 1 | 2012 | 4 | 0.100 |
Why?
|
| Mice | 4 | 2025 | 5936 | 0.100 |
Why?
|
| Models, Biological | 2 | 2021 | 739 | 0.100 |
Why?
|
| Feces | 1 | 2013 | 154 | 0.100 |
Why?
|
| Kidney | 1 | 2017 | 722 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2013 | 455 | 0.090 |
Why?
|
| Pectins | 1 | 2011 | 1 | 0.090 |
Why?
|
| Polygalacturonase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Pasteurization | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gallic Acid | 1 | 2011 | 2 | 0.090 |
Why?
|
| Sulfites | 1 | 2011 | 2 | 0.090 |
Why?
|
| Food Additives | 1 | 2011 | 7 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1372 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2012 | 401 | 0.090 |
Why?
|
| Filtration | 1 | 2011 | 21 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 405 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2011 | 66 | 0.090 |
Why?
|
| Cognition | 2 | 2024 | 330 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2012 | 192 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2011 | 200 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 93 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2013 | 691 | 0.080 |
Why?
|
| Kinetics | 2 | 2009 | 622 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2025 | 205 | 0.080 |
Why?
|
| Caco-2 Cells | 1 | 2009 | 31 | 0.080 |
Why?
|
| Drug Stability | 1 | 2009 | 38 | 0.080 |
Why?
|
| Aged | 6 | 2021 | 10193 | 0.080 |
Why?
|
| Culture Media | 1 | 2009 | 98 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 179 | 0.080 |
Why?
|
| Pistacia | 1 | 2008 | 3 | 0.070 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2008 | 6 | 0.070 |
Why?
|
| Stroke | 1 | 2012 | 516 | 0.060 |
Why?
|
| Lipoproteins | 2 | 2021 | 40 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2019 | 2449 | 0.060 |
Why?
|
| Dietary Fats | 2 | 2002 | 129 | 0.060 |
Why?
|
| Apolipoproteins | 2 | 2019 | 14 | 0.060 |
Why?
|
| United States | 2 | 2012 | 5225 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2025 | 55 | 0.060 |
Why?
|
| Ethylenes | 1 | 2024 | 5 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2004 | 70 | 0.050 |
Why?
|
| Plant Proteins | 1 | 2024 | 70 | 0.050 |
Why?
|
| Fish Oils | 1 | 2023 | 14 | 0.050 |
Why?
|
| Sulfates | 1 | 2023 | 25 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2023 | 24 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 31 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2023 | 28 | 0.050 |
Why?
|
| Attention | 1 | 2024 | 167 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2002 | 24 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 25 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2002 | 116 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2022 | 6 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 731 | 0.050 |
Why?
|
| Vitamin E | 1 | 2002 | 77 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 909 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2002 | 138 | 0.050 |
Why?
|
| Obesity | 2 | 2022 | 1164 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 122 | 0.050 |
Why?
|
| Powders | 1 | 2021 | 25 | 0.040 |
Why?
|
| beta Carotene | 1 | 2020 | 9 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 602 | 0.040 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 31 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 719 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 38 | 0.040 |
Why?
|
| Camellia sinensis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1680 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2018 | 46 | 0.040 |
Why?
|
| Vasodilation | 1 | 2018 | 101 | 0.040 |
Why?
|
| Exercise Test | 1 | 2018 | 144 | 0.040 |
Why?
|
| Incidence | 2 | 2012 | 1076 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 199 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 317 | 0.030 |
Why?
|
| Heart | 1 | 2019 | 360 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2016 | 23 | 0.030 |
Why?
|
| Citrus sinensis | 1 | 2015 | 2 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1321 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2015 | 84 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 3945 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 87 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 6708 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2670 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 329 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 600 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2012 | 10 | 0.020 |
Why?
|
| Citrus | 1 | 2012 | 4 | 0.020 |
Why?
|
| United States Department of Agriculture | 1 | 2012 | 4 | 0.020 |
Why?
|
| Candy | 1 | 2012 | 3 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 41 | 0.020 |
Why?
|
| Vaccinium | 1 | 2010 | 1 | 0.020 |
Why?
|
| Apigenin | 1 | 2010 | 7 | 0.020 |
Why?
|
| Time | 1 | 2010 | 29 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 34 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2012 | 162 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 746 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 55 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2009 | 48 | 0.020 |
Why?
|
| Placebos | 1 | 2009 | 85 | 0.020 |
Why?
|
| Safety | 1 | 2009 | 80 | 0.020 |
Why?
|
| Registries | 1 | 2012 | 629 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 152 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 39 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1216 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1550 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 1348 | 0.010 |
Why?
|
| Acylation | 1 | 2002 | 6 | 0.010 |
Why?
|
| Glycosylation | 1 | 2002 | 103 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 6643 | 0.010 |
Why?
|